Pharmaceutical Contract Development and Manufacturing Market by Type - Global Industry Analysis & Forecast to 2027

Published On : August 2019 Pages : 164 Category: Pharma & Healthcare Report Code : HC084850

Pharmaceutical Contract Development and Manufacturing Market by Type (Finished Dosage Formulation (FDF) Development & Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing, Secondary Packaging) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Pharmaceutical Contract Development and Manufacturing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.  A contract manufacturing organization (CMO), called an contract development and manufacturing organization (CDMO), is an organization that serves different organizations in the pharmaceutical business on an agreement premise to give exhaustive administrations from medication advancement through medication producing.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Power Tools market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2019 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Baxter BioPharma solutions
  • Jubilant Life Sciences Limited
  • Catalent Inc.
  • Patheon Inc
  • Pfizer Inc.
  • Boehringer Ingelheim International GmbH.
  • Recipharm AB
  • Recipharm AB
  • Famar S.A.

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Pharmaceutical Contract Development and Manufacturing Market, By Type, Estimates and Forecast, 2016-2027 ($Million)

o    Finished Dosage Formulation (FDF) Development & Manufacturing

o    Active Pharmaceutical Ingredient (API) Manufacturing

o    Secondary Packaging

·         Pharmaceutical Contract Development and Manufacturing Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    Baxter BioPharma solutions

o    Jubilant Life Sciences Limited

o    Catalent Inc.

o    Patheon Inc

o    Pfizer Inc.

o    Boehringer Ingelheim International GmbH.

o    Recipharm AB

o    Recipharm AB

o    Famar S.A.

·         Pharmaceutical Contract Development and Manufacturing Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Pharmaceutical Contract Development and Manufacturing Market, By Country

o    U.S. Pharmaceutical Contract Development and Manufacturing Market

o    Canada Pharmaceutical Contract Development and Manufacturing Market

o    Mexico Pharmaceutical Contract Development and Manufacturing Market

o    Europe

§  Europe Pharmaceutical Contract Development and Manufacturing Market, By Country

·         Germany Pharmaceutical Contract Development and Manufacturing Market

o    UK Pharmaceutical Contract Development and Manufacturing Market

o    France Pharmaceutical Contract Development and Manufacturing Market

o    Russia Pharmaceutical Contract Development and Manufacturing Market

o    Italy Pharmaceutical Contract Development and Manufacturing Market

o    Rest of Europe Pharmaceutical Contract Development and Manufacturing Market

o    Asia-Pacific

§  Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market, By Country

o    China Pharmaceutical Contract Development and Manufacturing Market

o    Japan Pharmaceutical Contract Development and Manufacturing Market

o    South Korea Pharmaceutical Contract Development and Manufacturing Market

o    India Pharmaceutical Contract Development and Manufacturing Market

o    Southeast Asia Pharmaceutical Contract Development and Manufacturing Market

o    Rest of Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market

o    South America

§  South America Pharmaceutical Contract Development and Manufacturing Market

o    Brazil Pharmaceutical Contract Development and Manufacturing Market

o    Argentina Pharmaceutical Contract Development and Manufacturing Market

o    Columbia Pharmaceutical Contract Development and Manufacturing Market

o    Rest of South America Pharmaceutical Contract Development and Manufacturing Market

o    Middle East and Africa

§  Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market

o    Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market

o    UAE Pharmaceutical Contract Development and Manufacturing Market

o    Egypt Pharmaceutical Contract Development and Manufacturing Market

o    Nigeria Pharmaceutical Contract Development and Manufacturing Market

o    South Africa Pharmaceutical Contract Development and Manufacturing Market

o    Rest of MEA Pharmaceutical Contract Development and Manufacturing Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Pharmaceutical Contract Development And Manufacturing Market, By Type

5.1.     Introduction

5.2.     Global Pharmaceutical Contract Development And Manufacturing Revenue and Market Share by Type (2016-2019)

5.2.1.  Global Pharmaceutical Contract Development And Manufacturing Revenue and Revenue Share by Type (2016-2019)

5.3.     Finished Dosage Formulation (FDF) Development & Manufacturing

5.3.1.  Global Finished Dosage Formulation (FDF) Development & Manufacturing Revenue and Growth Rate (2016-2019)

5.4.     Active Pharmaceutical Ingredient (API) Manufacturing

5.4.1.  Global Active Pharmaceutical Ingredient (API) Manufacturing Revenue and Growth Rate (2016-2019)

5.5.     Secondary Packaging

5.5.1.  Global Secondary Packaging Revenue and Growth Rate (2016-2019)

6.       Pharmaceutical Contract Development And Manufacturing Market, By Region

6.1.     Introduction

6.2.     Global Pharmaceutical Contract Development And Manufacturing Revenue and Market Share by Regions

6.2.1.  Global Pharmaceutical Contract Development And Manufacturing Revenue by Regions (2016-2019)

6.3.     North America Pharmaceutical Contract Development And Manufacturing by Countries

6.3.1.  North America Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)

6.3.2.  North America Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)

6.3.3.  United States

6.3.3.1.  United States Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.3.4.  Canada

6.3.4.1.  Canada Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.3.5.  Mexico

6.3.5.1.  Mexico Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.     Europe Pharmaceutical Contract Development And Manufacturing by Countries

6.4.1.  Europe Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)

6.4.2.  Europe Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)

6.4.3.  Germany

6.4.3.1.  Germany Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.4.  France

6.4.4.1.  France Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.5.  UK

6.4.5.1.  UK Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.6.  Russia

6.4.6.1.  Russia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.7.  Italy

6.4.7.1.  Italy Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.     Asia-Pacific Pharmaceutical Contract Development And Manufacturing by Countries

6.5.1.  Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)

6.5.2.  Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)

6.5.3.  China

6.5.3.1.  China Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.4.  Japan

6.5.4.1.  Japan Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.5.  Korea

6.5.5.1.  Korea Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.6.  India

6.5.6.1.  India Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.6.     South America Pharmaceutical Contract Development And Manufacturing by Countries

6.6.1.  South America Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)

6.6.2.  South America Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)

6.6.3.  Brazil

6.6.3.1.  Brazil Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.6.4.  Argentina

6.6.4.1.  Argentina Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.6.5.  Columbia

6.6.5.1.  Columbia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.     Middle East and Africa Pharmaceutical Contract Development And Manufacturing by Countries

6.7.1.  Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)

6.7.2.  Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.5.  Egypt

6.7.5.1.  Egypt Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.7.  South Africa

6.7.7.1.  South Africa Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.8.  Turkey

6.7.8.1.  Turkey Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)

7.       Company Profiles

7.1.     Baxter BioPharma solutions

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     Jubilant Life Sciences Limited

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Catalent Inc.

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Patheon Inc

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Pfizer Inc.

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Boehringer Ingelheim International GmbH.

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Recipharm AB

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     Recipharm AB

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

7.9.     Famar S.A.

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.  Financial Overview

8.       Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.1.     Global Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2019-2027)

8.2.     Pharmaceutical Contract Development And Manufacturing Market Forecast by Regions (2019-2027)

8.2.1.  North America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.1.1.  United States Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.1.2.  Canada Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.1.3.  Mexico Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.  Europe Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.1.  Germany Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.2.  France Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.3.  UK Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.4.  Russia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.5.  Italy Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.2.6.  Rest of Europe Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.  Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.1.  China Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.2.  Japan Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.3.  Korea Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.4.  India Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.5.  Southeast Asia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.3.6.  Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.4.  South America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.4.1.  Brazil Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.4.2.  Argentina Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.4.3.  Columbia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.4.4.  Rest of South America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.  Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.1.  Saudi Arabia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.2.  United Arab Emirates Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.3.  Egypt Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.4.  Nigeria Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.5.  South Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.6.  Turkey Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.2.5.7.  Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)

8.3.     Pharmaceutical Contract Development And Manufacturing Market Forecast by Type (2019-2027)

8.3.1.  Pharmaceutical Contract Development And Manufacturing Forecast by Type (2019-2027)

8.3.2.  Pharmaceutical Contract Development And Manufacturing Market Share Forecast by Type (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Pharmaceutical Contract Development And Manufacturing Revenue and Revenue Share by Type (2016-2019)
Figure Global Finished Dosage Formulation (FDF) Development & Manufacturing Revenue and Growth Rate (2016-2019)
Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Revenue and Growth Rate (2016-2019)
Figure Global Secondary Packaging Revenue and Growth Rate (2016-2019)
Table Global Pharmaceutical Contract Development And Manufacturing Revenue by Regions (2016-2019)
Figure North America Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure North America Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)
Figure North America Pharmaceutical Contract Development And Manufacturing by Countries (2016-2019)
Figure North America Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)
Figure United States Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure United States Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Canada Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Mexico Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Europe Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)
Figure Europe Pharmaceutical Contract Development And Manufacturing by Countries (2016-2019)
Figure Europe Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)
Figure Germany Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Germany Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure France Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure UK Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Russia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Italy Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Rest of Europe Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Pharmaceutical Contract Development And Manufacturing by Countries (2016-2019)
Figure Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)
Figure China Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure China Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Japan Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Korea Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure India Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Southeast Asia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure South America Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)
Figure South America Pharmaceutical Contract Development And Manufacturing by Countries (2016-2019)
Figure South America Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Brazil Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Argentina Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Columbia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Rest of South America Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Pharmaceutical Contract Development And Manufacturing by Countries (2016-2019)
Figure Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Saudi Arabia Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure United Arab Emirates Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Egypt Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Nigeria Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure South Africa Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Turkey Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2016-2019)
Table Baxter BioPharma solutions Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Jubilant Life Sciences Limited Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Catalent Inc. Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Patheon Inc Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Pfizer Inc. Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Boehringer Ingelheim International GmbH. Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Recipharm AB Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Recipharm AB Pharmaceutical Contract Development And Manufacturing Financial Overview
Table Famar S.A. Pharmaceutical Contract Development And Manufacturing Financial Overview
Figure Global Pharmaceutical Contract Development And Manufacturing Revenue (Millions USD) and Growth Rate (2019-2027)
Table Pharmaceutical Contract Development And Manufacturing Market Forecast by Regions (2019-2027)
Figure North America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure United States Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Canada Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Mexico Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Europe Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Germany Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure France Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure UK Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Russia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Italy Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Rest of Europe Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure China Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Japan Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Korea Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure India Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Southeast Asia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure South America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Brazil Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Argentina Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Columbia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Rest of South America Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Saudi Arabia Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure United Arab Emirates Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Egypt Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Nigeria Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure South Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Turkey Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Pharmaceutical Contract Development And Manufacturing Market Forecast (2019-2027)
Figure Global Pharmaceutical Contract Development And Manufacturing Forecast by Type (2019-2027)
Figure Global Pharmaceutical Contract Development And Manufacturing Market Share Forecast by Type (2019-2027)
Figure Global Pharmaceutical Contract Development And Manufacturing Forecast by Type (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*